Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6469776

COc1cc(OC)c2nc(Nc3nc(O)c4cc(N)cc(OC)c4n3)nc(C)c2c1.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.35
MEN1 O00255 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
GAA P10253 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
KDM4E B2RXH2 4/20 0.33
DPP4 P27487 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
RAD52 P43351 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
JAK2 O60674 1/20 0.32
TDP2 O95551 1/20 0.32
NOS1 P29475 1/20 0.32
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6465684 0.95 KMT2A (0.33) KMT2AMEN1CYP1A2CYP3A4GAA
Trifluoroacetic Acid SCHEMBL6467460 0.91 KDM4E (0.45) KMT2AMEN1KDM4ESMN1; SMN2LMNA
Trifluoroacetic Acid SCHEMBL6467955 0.88 STAT3 (0.39) KMT2AMEN1CYP1A2CYP3A4GAA
Trifluoroacetic Acid SCHEMBL6470553 0.85 GAA (0.42) KMT2AMEN1CYP1A2CYP3A4GAA
Trifluoroacetic Acid SCHEMBL6470460 0.85 KMT2A (0.35) KMT2AMEN1CYP1A2CYP3A4GAA
Trifluoroacetic Acid SCHEMBL6470355 0.84 KMT2A (0.35) KMT2AMEN1CYP1A2CYP3A4GAA
SCHEMBL6469779 0.84 KMT2A (0.32) KMT2AMEN1CYP1A2CYP3A4GAA
Trifluoroacetic Acid SCHEMBL6467088 0.83 TYMS (0.35) KMT2AMEN1SMN1; SMN2LMNANPSR1
Trifluoroacetic Acid SCHEMBL6470554 0.82 KDM4E (0.46) KMT2AMEN1KDM4ESMN1; SMN2LMNA
Trifluoroacetic Acid SCHEMBL6467073 0.81 KMT2A (0.39) KMT2AMEN1KDM4ESMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB KMT2A 2156/4885MEN1 4218/4885CYP1A2 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.